News & Articles

Studying these organoids could help researchers develop and test new treatments for pancreatic cancer, one of the deadliest types of cancer.

Gain insights on a range of current topics, including clinical microbiology, vaccine design, cell viability and more

Highly consistent and scalable supply of lab grown human skeletal muscle cells provide an effective and biologically relevant tool for research and drug development

Gain insights on topics from immunotyping and cell sorting to clinical QC, 3D imaging and more

Diadem announces publication of clinical data showing its AlzoSure biomarker test is able to predict progression to Alzheimer’s disease years before symptoms are displayed.

Talks from world-leading scientists in the field of neuroscience now available on demand

Watch this on-demand webinar to discover Abcam’s manufacturing workflow for producing bioactive proteins

Teams uses mathematical modelling study to guide preparations for future health strategies

A first of its kind study demonstrates voltage outside of biological cells, with potential implications for cardiovascular disease, cancer and fertility treatment

Including a new section for embedded organoid assays, and new data on mitochondrial membrane potential assays and phagocytosis assays

New life sciences brand enables breakthroughs to market with a fully integrated portfolio which promises unparalleled sample exploration and management solutions

Abcam scientist, Dr. Jimmy Theriault, discusses how to determine if proteins are functionally active using cell-based and biochemical assays

The panels complete Bio-Rad’s set of Bio-Plex™ Pro Multiplex SARS-CoV-2 Human Serology Panels for detection of antibodies against four SARS-CoV-2 antigens

Gain insights on topics from antibody performance and cell line development to food safety method validation and more

New module is designed to provide life science researchers with high-resolution images

The FDA cleared the first new major technological improvement for Computed Tomography (CT) imaging in nearly 10 years

Latest technologies aim to improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell and gene therapy, autoimmune disease and drugs of abuse

Customers will benefit from enhanced development and manufacturing capabilities, including high-density microarray printing

Measurement of anti-S1/RBD antibodies, neutralizing antibodies targeting S1/RBD, and specific T-cells using EUROIMMUN tests supports evaluation of the immune reaction to SARS-CoV-2 following vaccination or infection